Compare RAIL & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAIL | QTRX |
|---|---|---|
| Founded | 1901 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.9M | 160.0M |
| IPO Year | 2005 | 2017 |
| Metric | RAIL | QTRX |
|---|---|---|
| Price | $7.84 | $3.42 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 139.3K | ★ 877.3K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.94 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $500,991,000.00 | $37,632,000.00 |
| Revenue This Year | $6.54 | $25.49 |
| Revenue Next Year | $30.90 | $10.04 |
| P/E Ratio | $7.39 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $6.02 | $2.95 |
| 52 Week High | $14.90 | $8.77 |
| Indicator | RAIL | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 47.12 |
| Support Level | $7.78 | $3.30 |
| Resistance Level | $10.09 | $3.81 |
| Average True Range (ATR) | 0.46 | 0.24 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 21.05 | 67.32 |
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.